We are a Spanish biotech company founded in 2017 by entrepreneurs with extensive experience in discovery and development of pharmaceuticals.
We specialize on research and development of small molecules that address health disorders related to TGF-β signaling dysfunction, among these fibrosis and cancer.
We focus on drug discovery and early development of novel medicines with high unmet medical need.
The discovery and development of next generation therapeutic products for treatment of severe diseases linked to TGF-β.
To improve life quality and ultimately, contribute to the curing of people suffering from devastating medical conditions.